Common factors such as education, ethnicity, income, and marital status do not appear to be risk factors for the development of MDD. Instead, MDD often emerges subsequent to a significant ...

She confirmed the presence of the disorder and reported ... Overcoming Depression: A Cognitive-Behavioral Protocol for the Treatment of Depression. Oakland, Calif: New Harbinger Publications ...

de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

its Phase 3 pivotal program evaluating the efficacy and safety of CYB003 for the adjunctive treatment of Major Depressive Disorder (“MDD”). The program name, PARADIGM, represents the Company's ...

Cybin launches Phase 3 trials for CYB003, aiming to offer lasting relief for Major Depressive Disorder. Backed by promising ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in mood — both high and low — that can ...

Generalized anxiety disorder (GAD) and major ... depression. You don't need an official anxiety or depression diagnosis to ...

Major depressive disorder can potentially be a lifelong illness ... Certain lifestyle changes and habits can support the treatment and management of endogenous depression. The following strategies for ...

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in ... and then go over treatment options and coping strategies. Bipolar I is thought to be the most common ...